Abstract
Much of the recent advances in gastroenterology has focused on the small bowel. Reimbursement is generally poor considering the time, expertise, and equipment required. Our current billing system lags behind technology and as a result, many of these newer procedures operate at a net loss in income. Previous studies have shown that downstream revenue generation from other resource intensive procedures such as ERCP, EUS, and EMR attenuates the loss of income from the procedure itself. No studies to date have specifically analyzed small bowel-directed endoscopies and their revenue generating profile.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
